000 | 01478 a2200385 4500 | ||
---|---|---|---|
005 | 20250513060841.0 | ||
264 | 0 | _c19941010 | |
008 | 199410s 0 0 ger d | ||
022 | _a0179-7158 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aStuschke, M | |
245 | 0 | 0 |
_a[Value of neoadjuvant radiochemotherapy in undifferentiated soft tissue sarcomas]. _h[electronic resource] |
260 |
_bStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] _cAug 1994 |
||
300 |
_a480-3 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial | ||
650 | 0 | 4 |
_aAdjuvants, Immunologic _xadministration & dosage |
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
650 | 0 | 4 | _aChild |
650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIfosfamide _xadministration & dosage |
650 | 0 | 4 | _aInfusions, Parenteral |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aRadiotherapy Dosage |
650 | 0 | 4 |
_aSarcoma _xdrug therapy |
650 | 0 | 4 |
_aSoft Tissue Neoplasms _xdrug therapy |
650 | 0 | 4 | _aTime Factors |
773 | 0 |
_tStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] _gvol. 170 _gno. 8 _gp. 480-3 |
|
999 |
_c8084537 _d8084537 |